In AD, the aggregation and accumulation of Aβ and tau protein are then followed by a series of metabolic dysfunction processes, such as pro-inflammatory cytokines induction, reactive oxygen species production, oxidative stress development, and mitochondrial abnormalities (Origlia et al., 2010). The gene discussed is MAPT; the disease is Alzheimer disease.